PTAB Denies Institution of Inter Partes Review on Oxford Immunotec patent

February 22, 2017 – The Patent Trial and Appeal Board denied Qiagen Inc.’s petition for inter partes review of claims 1 through 22 of Oxford Immunotec Ltd.’s U.S. Patent Number 8,216,795, “Tuberculosis diagnostic test.”

The case is IPR2016-01556.

By: Joyce L. Nadipuram